Bridging the Fair Share Gap for Antibacterial Innovation: an Observational Analysis of Antibacterial Revenues in the G7 and EU27

Among high-income countries, the G7 and EU countries fall short of revenue targets needed to sustain research for new antibiotic development, with the UK and Italy as notable exceptions. Revenue guarantee incentives could help bridge gaps in antibiotic investment in wealthier countries amid a growing threat of antimicrobial resistance.